Cardiovascular regeneration stands at the forefront of transformative medical research, offering a paradigm shift in the treatment of heart-related ailments. In the relentless pursuit of innovative therapeutic strategies, scientists are exploring novel avenues to regenerate damaged cardiovascular tissues. Beyond traditional methods, cutting-edge technologies like CRISPR gene editing and precision medicine are being harnessed to customize treatments for individual patients. The evolving landscape of cardiovascular regeneration not only holds promise for repairing heart tissues but also for revolutionizing personalized medicine in the realm of cardiac care. By unlocking the regenerative potential within our own bodies and integrating groundbreaking technologies, the field of cardiovascular regeneration represents a beacon of hope for a future where heart health is not merely managed but actively restored.
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : CARDIAC TROPONIN AND HOMOCYSTEINE LEVELS IN HEMODIALYSIS PATIENTS: ASSOCIATION WITH DIALYSIS VINTAGE AND CARDIOVASCULAR COMORBIDITY
Sofra Maria, Aretaieion University Hospital, Greece
Title : New recommendations for the prevention of sudden cardiac death in athletes and recreational sports
Sekib Sokolovic, ASA Hospital Sarajevo, Bosnia and Herzegowina
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation